Cell Therapy for Periodontal, Soft-Tissue, and Craniofacial Regeneration.

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Dental Research

Background:

• Periodontal and craniofacial regeneration face challenges due to complex tissue structure, poor vascularization, and low stem cell counts.
• Current treatments like bone grafts have limitations including donor site morbidity and insufficient regenerative capacity.

Purpose of the Study:

• To review mesenchymal stem/stromal cell (MSC)-based therapies for periodontal and craniofacial reconstruction.
• To discuss current research, existing obstacles, and future prospects in MSC-based tissue regeneration.

Main Methods:

• Literature review of preclinical and clinical studies on MSC-based therapies.
• Evaluation of recent findings, challenges, and emerging technologies in the field.

Main Results:

• MSC-based therapies demonstrate potential for soft and hard tissue regeneration due to multipotency, immunomodulation, and paracrine signaling.
• Significant obstacles include lack of standardization, scalability issues, regulatory hurdles, and limited biomaterial options.

Conclusions:

• MSC therapies offer a promising biologically driven approach for periodontal and craniofacial regeneration.
• Advanced biofabrication techniques like 3D printing and bioprinting are key to future personalized cell therapies.